Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,571 | 1,352 | 11,520 | 19,697 | -5,506 |
| Depreciation Amortization | 112 | 31 | 22 | 12 | 13 |
| Accounts receivable | -14,311 | -262 | -1,026 | 1,448 | -4,660 |
| Accounts payable and accrued liabilities | 356 | 10,647 | 1,282 | 1,884 | -558 |
| Other Working Capital | -16,725 | 2,483 | 308 | 5,470 | -2,666 |
| Other Operating Activity | 18,279 | -7,170 | 1,610 | -2,675 | 5,502 |
| Operating Cash Flow | $-9,718 | $7,081 | $13,716 | $25,836 | $-7,875 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | -24,000 | -89,999 | -15,998 | 19,999 |
| PPE Investments | -1,881 | -1,398 | -327 | -43 | -11 |
| Investing Cash Flow | $-1,881 | $-25,398 | $-90,326 | $-16,041 | $19,988 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 55,813 | 55,427 | 55,427 | 55,260 | 34 |
| Financing Cash Flow | $55,813 | $55,427 | $55,427 | $55,260 | $34 |
| Beginning Cash Position | 34,869 | 34,869 | 34,869 | 34,869 | 22,722 |
| End Cash Position | 79,083 | 71,979 | 13,686 | 99,924 | 34,869 |
| Net Cash Flow | $44,214 | $37,110 | $-21,183 | $65,055 | $12,147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,718 | 7,081 | 13,716 | 25,836 | -7,875 |
| Capital Expenditure | -1,881 | -1,398 | -327 | -43 | -11 |
| Free Cash Flow | -11,599 | 5,683 | 13,389 | 25,793 | -7,886 |